The neuromodulation-focused Stanford spinout increased its overall funding to $145m in a round led by Ascension Ventures.
Venture capital firm Ascension Ventures led a $77m funding round on Tuesday for Cala Health, a US-based manufacturer of neuromodulation devices based on Stanford University research. The round also featured Peak6 Strategic Capital, Innovatus Capital Partners, Dolby Family Ventures and all the company’s existing investors, which include pharmaceutical firms Novartis and Johnson & Johnson, internet…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Fernando Moncada Rivera
Fernando Moncada Rivera is a reporter at Global Corporate Venturing and also host of the CVC Unplugged podcast.
